Auto-Injectors Market: Segment Snapshot and Table of Content (2016-2026)

Auto-Injectors are expected to present vast opportunities to investors due to high demand in biologics development. Overall revenues from the pre-filled syringes segment is expected to grow during the forecast period due to the rising need for targeted and sustained drug delivery. In September 2015, Bayer Healthcare reported the launch of Betaconnect – the only electronic auto-injector for the treatment of relapsing-remitting multiple sclerosis (RRMS). The procedure does not require a visit to hospitals, clinics, etc. and reduces dependency on healthcare professionals, which is why auto-injectors are becoming a choice of therapy for patients suffering from anaphylaxis, multiple sclerosis, rheumatoid arthritis and others. Increasing adoption of auto-injectors due to benefits such as increased safety, accuracy and minimal discomfort is expected to fuel market revenue growth over the forecast period.

Report overview@ https://www.futuremarketinsights.com/reports/auto-injectors-market

The global auto-injectors market was valued at nearly US$ 1700 Mn in 2016. The market is anticipated to exhibit a CAGR of 15.1% during the forecast period and is projected to be valued at nearly US$ 7,000 Mn by the end of 2026.

Anaphylaxis segment dominated the global auto-injectors market by indication in terms of revenue in 2015 and the trend is projected to sustain throughout the forecast period. Anaphylaxis segment is the most attractive segment with an attractiveness index of 3.55 over the forecast period. Revenue from the anaphylaxis segment is anticipated to register a CAGR of 15% over 2016–2026, to reach more than US$ 6,000 Mn by 2026. Multiple sclerosis segment is expected to be the second most lucrative segment in the global auto-injectors market by indication, with an attractiveness index of 0.2 during the forecast period. Multiple sclerosis segment accounted for 5.3% value share in 2016 and is projected to account for 5.5% share by 2026 end.

Request to sample report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1642

Summary of Table of Content

1. Executive Summary

2. Market Introduction

3. Auto Injectors Market Analysis Scenario

4. Market Dynamics

5. Global Auto Injectors Market Analysis and Forecast, By Product Type

6. Global Auto Injectors Market Analysis and Forecast, By Therapeutic Area

7. Global Auto Injectors Market Analysis and Forecast, By Distribution Channel

8. Global Auto Injectors Market Analysis and Forecast, By Region

9. North America Auto Injectors Market Analysis and Forecast

10. Latin America Auto Injectors Market Analysis and Forecast

11. Western Europe Auto Injectors Market Analysis and Forecast

12. Eastern Europe Auto Injectors Market Analysis and Forecast

13. Asia Pacific Excl. Japan (APEJ) Auto Injectors Market Analysis and Forecast

14. Japan Auto Injectors Market Analysis and Forecast

15. Middle East and Africa (MEA) Auto Injectors Market Analysis and Forecast

16. Competition Landscape

17. Assumptions and Acronyms Used

18. Research Methodology

Request to Browse Full Table of Content, figure and Tables@ https://www.futuremarketinsights.com/reports/auto-injectors-market/toc

ABOUT US:

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:

Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.